<unk>  is a lung surfactant that is FDA approved for the treatment of Respiratory Distress Syndrome (RDS) in premature infants.   Common adverse reactions include bradycardia, hypotension, endotracheal tube blockage, and oxygen desaturation.
Poractant Alfa
Dictyostelid
Gadoteric acid
Podofilox
Oprelvekin
Bioallethrin
Irofulven
Pegloticase